Product Details
Alternative Name: | MAP2K7, MAP kinase kinase 7 |
|
Clone: | 10F7 |
|
Host: | Mouse |
|
Isotype: | IgG1 |
|
Immunogen: | Synthetic peptide corresponding to the sequence near the amino terminus of MKK7 (MAP2K7) conjugated to hemocyanin. |
|
UniProt ID: | O14733 |
|
Species reactivity: | Human, Mouse, Rat Dog
|
|
Applications: | ELISA, ICC, IHC, WB
|
|
Recommended Dilutions/Conditions: | ELISA (0.1µg/ml) Immunohistochemistry (1:50) Western Blot (0.5µg/ml, ECL) Suggested dilutions/conditions may not be available for all applications. Optimal conditions must be determined individually for each application. |
|
Application Notes: | Detects a band of ~45kDa by Western blot. |
|
Purity Detail: | Thiophilic adsorption and size exclusion chromatography purified. |
|
Formulation: | Lyophilized from 1ml of 2x PBS containing 0.09% sodium azide, PEG, and sucrose. |
|
Reconstitution: | Reconstitute with 1ml water (15 minutes at room temperature). |
|
Use/Stability: | Stable at -80°C up to 1 year, at 4°C up to 3 months. |
|
Shipping: | Blue Ice |
|
Long Term Storage: | -20°C |
|
Scientific Background: | Members of the MAP kinase family of protein kinases (e.g. p38 and Jnk) are subject to dual phosphorylation of a conserved T-X-Y motif in their activation domain by upstream members of the MAP/ERK kinase (MEK/MKK) family. MKK3 and MKK6 phosphorylate p38 in response to cytokine stimulation and cellular stress, while MKK7 and MKK4 activate the Jnk kinases by phosphorylation of the threonine and tyrosine residues, respectively. |
|
Regulatory Status: | RUO - Research Use Only |
|
Western blot analysis of serum starved cancer cells with MKK7 (MAP2K7) mAb (10F7); A431 (1), A549 (2), SK0V3 (3), OVCAR5 (4), HaCaT (5), PC3 (6), HeLa (7), HepG2 (8).
Immunofluorescent analysis (confocal) staining of Caco2 cells using MKK7 (MAP2K7) mAb (10F7) (green); nuclei are stained in blue pseudocolor using DRAQ5.
Immunohistochemistry analysis of human lung cancer tissue with MKK7 (MAP2K7) mAb (10F7).
Please mouse over
Product Literature References
TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice: F. Wandrer, et al.; Cell Death Dis.
11, 212 (2020),
Abstract;
Full Text